Eli Lilly’s Inluriyo is approved for treating advanced breast cancer
FDA Approves New Treatment for Advanced Breast Cancer The U.S. Food and Drug Administration has green-lighted a new option for treating advanced breast cancer. Eli Lilly announced the approval of Inluriyo, which is an oral estrogen receptor antagonist, on September 25. This drug is aimed at adults suffering from specific types of the disease. These […]